↧
Neptune’s krill oil battles CV disease three ways
CFO André Godin An omega-3 phospholipid isolated from shrimp-like krill that ply the waters of the Antarctic Ocean may hold the key to a breakthrough cardiovascular therapeutic that helps reduce levels...
View ArticleMatinas presents positive omega-3 data versus Vascepa
Matinas BioPharma Holdings (OTCQB:MTNB) has presented data from a head-to-head study that showed MAT9001, its prescription-only omega-3 fatty acid-based composition under development for the treatment...
View ArticleViking Therapeutics to complete two POC trials in 2016
Viking Therapeutics (NASDAQ:VKTX) expects to complete two proof-of-concept Phase 2 trials in 2016 in patients recovering from hip fracture surgery, and in patients with very high levels of cholesterol...
View Article